25.01.2023 23:58:00

DoubleVerify Holdings to Join S&P SmallCap 600

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, January 31. SD Biosensor is acquiring Meridian Bioscience in a deal expected to be completed soon pending final conditions.

S&P Dow Jones Indices logo (PRNewsfoto/S&P Dow Jones Indices)

Following is a summary of the change that will take place prior to the open of trading on the effective date:

Effective Date

Index Name      

Action

Company Name

Ticker

GICS Sector

January 31, 2023

S&P SmallCap 600

Addition

DoubleVerify Holdings

DV

Information Technology


S&P SmallCap 600

Deletion

Meridian Bioscience

VIVO

Health Care

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/doubleverify-holdings-to-join-sp-smallcap-600-301731036.html

SOURCE S&P Dow Jones Indices

Nachrichten zu Meridian Bioscience Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Meridian Bioscience Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

S&P Global Inc 494,05 0,38% S&P Global Inc